<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02848898</url>
  </required_header>
  <id_info>
    <org_study_id>71/15</org_study_id>
    <nct_id>NCT02848898</nct_id>
  </id_info>
  <brief_title>The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Patients</brief_title>
  <official_title>The Effects of Focal Vibration on Central and Peripheral Spasticity in Multiple Sclerosis Patients. A Randomized, Multicenter, Double Blinded vs Placebo Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial consists of application of little devices (named EquistasiÂ®) generating focal
      vibrations to treat spasticity in neurological patients, affected by multiple sclerosis. The
      expected effects are on gait and postural instability.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait Velocity</measure>
    <time_frame>one year</time_frame>
    <description>evaluation of gait velocity in m/s</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First step length</measure>
    <time_frame>one year</time_frame>
    <description>first step length in cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swing phase</measure>
    <time_frame>one year</time_frame>
    <description>swing phase measured in seconds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stance phase</measure>
    <time_frame>one year</time_frame>
    <description>stance phase measured in seconds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Double support time</measure>
    <time_frame>one year</time_frame>
    <description>double support time measured in seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>H/M ratio</measure>
    <time_frame>one year</time_frame>
    <description>evaluation of neurophysiological modifications in treated patients vs placebo group, as ratio between H max and M max in tibial posterior nerve, in Unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berg Balance Scale</measure>
    <time_frame>one year</time_frame>
    <description>Evaluation of balance with a self administered scale, measured in Unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Fatigue Scale</measure>
    <time_frame>one year</time_frame>
    <description>evaluation of fatigue with a self administered scale, measured in Unit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Equistasi Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>arm treated with application of devices</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>arm treated with application of inactivated devices</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Equistasi</intervention_name>
    <arm_group_label>Equistasi Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Multiple Sclerosis affected

          -  Spasticity

          -  EDSS (Expanded Disability Status Scale) 0 - 5,5

          -  Patients able to sign informed consent

        Exclusion Criteria:

          -  Age less than 18 years old and more than 65 years old

          -  Pacemaker

          -  Pregnancy

          -  Comorbidities as: cancer, hypertension not controlled by drugs

          -  concurrent therapies with antidepressant or corticosteroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Prof. Giuseppe Orefice</name>
      <address>
        <city>Naples</city>
        <state>Campania</state>
        <zip>81025</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2016</study_first_posted>
  <last_update_submitted>July 26, 2016</last_update_submitted>
  <last_update_submitted_qc>July 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Emanuele Spina</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <keyword>Focal Vibrations</keyword>
  <keyword>Neurorehabilitation</keyword>
  <keyword>Spasticity</keyword>
  <keyword>Multiple Sclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Muscle Spasticity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

